Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$479M |
| 2 |
Meta Platforms (Facebook)
META
|
+$465M |
| 3 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$445M |
| 4 |
Kenvue
KVUE
|
+$434M |
| 5 |
Micron Technology
MU
|
+$431M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$3.24B |
| 2 |
Apple
AAPL
|
+$1.9B |
| 3 |
Microsoft
MSFT
|
+$1.56B |
| 4 |
PepsiCo
PEP
|
+$1.34B |
| 5 |
JPMorgan Chase
JPM
|
+$1.34B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.7% |
| 2 | Financials | 7.47% |
| 3 | Consumer Discretionary | 6.7% |
| 4 | Communication Services | 6.02% |
| 5 | Healthcare | 4.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Deere & Co
DE
$168B
| $263M | 0.06% |
564,970
-47,552
| -8% | -$22.3M |
|
227
Western Digital
WDC
$150B
| $263M | 0.06% |
1,526,384
+298,897
| +24% | +$45.3M |
|
228
iShares Bitcoin Trust
IBIT
$48.4B
| $262M | 0.06% |
5,286,036
+978,895
| +23% | +$55.6M |
|
229
CSX Corp
CSX
$93.1B
| $261M | 0.06% |
7,191,572
+281,953
| +4% | +$10.1M |
|
230
American Tower
AMT
$80.4B
| $256M | 0.06% |
1,455,379
-128,845
| -8% | -$23.4M |
|
231
Travelers Companies
TRV
$80.2B
| $255M | 0.06% |
878,468
-423,893
| -33% | -$119M |
|
232
KKR & Co
KKR
$92.3B
| $255M | 0.06% |
1,998,178
-700,153
| -26% | -$87.1M |
|
233
AstraZeneca
AZN
$250B
| $252M | 0.06% |
1,372,802
+1,029,039
| +299% | +$180M |
|
234
ON Semiconductor
ON
$31.6B
| $252M | 0.06% |
4,660,373
-134,727
| -3% | -$6.91M |
|
|
AMRZ
235
Amrize Ltd
AMRZ
$25.8B
| $250M | 0.06% |
4,614,593
+2,281,831
| +98% | +$116M |
|
236
Take-Two Interactive
TTWO
$46.1B
| $250M | 0.06% |
974,584
+92,716
| +11% | +$23.1M |
|
237
Cardinal Health
CAH
$55.4B
| $248M | 0.06% |
1,208,599
-375,615
| -24% | -$70.7M |
|
238
Newmont
NEM
$119B
| $247M | 0.06% |
2,474,306
-1,948,883
| -44% | -$176M |
|
239
Wheaton Precious Metals
WPM
$60.9B
| $246M | 0.06% |
2,092,934
+930,190
| +80% | +$99.6M |
|
240
Motorola Solutions
MSI
$77.4B
| $245M | 0.06% |
639,119
-49,698
| -7% | -$20M |
|
241
Intercontinental Exchange
ICE
$84.4B
| $245M | 0.06% |
1,512,297
+103,157
| +7% | +$16.2M |
|
242
Duke Energy
DUK
$97.3B
| $244M | 0.06% |
2,077,591
-267,833
| -11% | -$32.7M |
|
|
EA
243
DELISTED
Electronic Arts
EA
| $243M | 0.06% |
1,188,261
+114,045
| +11% | +$23M |
|
244
PUT
iShares MSCI Emerging Markets ETF
EEM
$30B
| $242M | 0.06% |
4,431,300
-3,218,700
| -42% | -$175M |
|
245
News Corp Class A
NWSA
$15.4B
| $241M | 0.06% |
9,226,138
-5,649,477
| -38% | -$148M |
|
246
Regeneron Pharmaceuticals
REGN
$80.8B
| $240M | 0.06% |
311,167
-14,754
| -5% | -$10M |
|
247
Canadian Pacific Kansas City
CP
$80.5B
| $240M | 0.06% |
3,261,276
+14,086
| +0.4% | +$1.04M |
|
248
CALL
State Street Utilities Select Sector SPDR ETF
XLU
$22.7B
| $239M | 0.06% |
5,600,000
+5,570,000
| +18,567% | +$247M |
|
249
Nike
NKE
$61.9B
| $237M | 0.06% |
3,719,313
-84,025
| -2% | -$5.48M |
|
250
TotalEnergies
TTE
$190B
| $237M | 0.06% |
3,621,012
+3,585,604
| +10,127% | +$227M |
|
Similar funds
Barclays's Q4 2025 Portfolio in Review
As of Q4 2025, Barclays held 5,847 positions worth $417B, down 9.7% from $461B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
Barclays withdrew a net $49.1B in Q4 2025, closing 641 positions and reducing 1,715 holdings. Its most notable exit was Verona Pharma, an estimated $149M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in The Magnum Ice Cream Company N.V. worth $156M.
- Barclays's largest Q4 2025 buy was The Magnum Ice Cream Company N.V.: 9,862,859 shares worth $156M.
- Barclays added most to Gilead Sciences in Q4 2025, an estimated $479M increase.
- Barclays's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $3.24B.
- Barclays fully exited Verona Pharma in Q4 2025, selling an estimated $149M.
- Barclays's ten largest holdings make up 35% of its $417B portfolio in Q4 2025.
- Barclays opened 403 new positions and closed 641 in Q4 2025.
- Barclays's portfolio value fell 9.7% quarter-over-quarter to $417B.
Based on Barclays's 13F filing for Q4 2025, filed 13 Feb 2026.